申请人:Xu Yong
公开号:US20140329807A1
公开(公告)日:2014-11-06
The present invention provides protein kinase having one of the following structures (I), (II) or (III): or a stereoisomer, prodrug, tautomer or pharmaceutically acceptable salt thereof, wherein R, R
1
, R
2
and X are as defined herein. Compositions and methods for using the same in the treatment of cancer, autoimmune, inflammatory and other Pim kinase-associated conditions are also disclosed.
本发明提供具有以下结构之一(I),(II)或(III)的蛋白激酶:或其立体异构体,前药,互变异构体或药学上可接受的盐,其中R,R1,R2和X如本文所定义。还公开了在治疗癌症,自身免疫,炎症和其他Pim激酶相关疾病中使用相同的组合物和方法。